Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Early research (Phase 1)Study completedNCT04409925
What this trial is testing

DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)

Who this might be right for
COVID-19 Infection
McGill University Health Centre/Research Institute of the McGill University Health Centre 15
Large-scale testing (Phase 3)Study completedNCT02600325
What this trial is testing

Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV

Who this might be right for
Acute Hepatitis CHuman Immunodeficiency VirusHepatitis C
Erasmus Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT02174276
What this trial is testing

Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 195
Early research (Phase 1)UnknownNCT04474340
What this trial is testing

COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients

Who this might be right for
Moderate COVID-19 Pneumonia, Severe COVID-19 PneumoniaPneumonia, Viral
Ministry of Health, Kuwait 300
Large-scale testing (Phase 3)Study completedNCT04640168
What this trial is testing

Adaptive COVID-19 Treatment Trial 4 (ACTT-4)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 1,010
Not applicableStudy completedNCT05572450
What this trial is testing

Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

Who this might be right for
Influenza A H1N1
Hvivo 70
Not applicableUnknownNCT05890508
What this trial is testing

Electro-acupuncture for Long Covid Neuropsychiatric Symptoms

Who this might be right for
Long Covid19Neuropsychiatric SymptomsElectro-acupuncture
Hong Kong Baptist University 150
Not applicableUnknownNCT05926076
What this trial is testing

COVID-19 Infection

Who this might be right for
COVID-19Renal Transplant Infection
Tianjin First Central Hospital 610
Not applicableStudy completedNCT02827240
What this trial is testing

Zambian Peer-Educators for HIV Self-Testing Study

Who this might be right for
HIV Infection
Harvard School of Public Health (HSPH) 965
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT05406089
What this trial is testing

Effects of Antiviral Therapy on Patients With HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaHepatitis B VirusSurvival
First Affiliated Hospital Xi'an Jiaotong University 494
Testing effectiveness (Phase 2)Study completedNCT01640691
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic Influenza
Adimmune Corporation 39
Large-scale testing (Phase 3)Study completedNCT00036608
What this trial is testing

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb
Large-scale testing (Phase 3)WithdrawnNCT01517308
What this trial is testing

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

Who this might be right for
Chronic Hepatitis C
Federico II University
Large-scale testing (Phase 3)WithdrawnNCT00381017
What this trial is testing

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Who this might be right for
Hepatitis CLiver CirrhosisHIV Infections
Merck Sharp & Dohme LLC
Not applicableUnknownNCT05157217
What this trial is testing

Impact of the Genetic Polymorphism on COVID-19 in Egypt

Who this might be right for
COVID-19
Cairo University 98
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Early research (Phase 1)Study completedNCT01638650
What this trial is testing

Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 23
Not applicableStudy completedNCT00000950
What this trial is testing

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Next Page